CUAMC
HARP

China Universal Asset Management Company’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

China Universal Asset Management Company’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31
Closed – – 494
2022
Q3 		$0 Buy
+31
New +$579 ﹤0.01% 470

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

China Universal Asset Management Company's HARP Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 31 shares.

China Universal Asset Management Company first reported a position in HARP in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 31 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022.
  • China Universal Asset Management Company first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Harpoon Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.